Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply

Detalles Bibliográficos
Autores principales: Oronsky, Bryan, Larson, Christopher, Caroen, Scott, Reid, Tony R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636028/
https://www.ncbi.nlm.nih.gov/pubmed/36347457
http://dx.doi.org/10.1016/j.ijid.2022.11.001
_version_ 1784824845177978880
author Oronsky, Bryan
Larson, Christopher
Caroen, Scott
Reid, Tony R.
author_facet Oronsky, Bryan
Larson, Christopher
Caroen, Scott
Reid, Tony R.
author_sort Oronsky, Bryan
collection PubMed
description
format Online
Article
Text
id pubmed-9636028
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-96360282022-11-07 Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply Oronsky, Bryan Larson, Christopher Caroen, Scott Reid, Tony R. Int J Infect Dis Letter to the Editor The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-12 2022-11-05 /pmc/articles/PMC9636028/ /pubmed/36347457 http://dx.doi.org/10.1016/j.ijid.2022.11.001 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Oronsky, Bryan
Larson, Christopher
Caroen, Scott
Reid, Tony R.
Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title_full Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title_fullStr Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title_full_unstemmed Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title_short Could nucleocapsid be a next-generation COVID-19 vaccine candidate – author's reply
title_sort could nucleocapsid be a next-generation covid-19 vaccine candidate – author's reply
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636028/
https://www.ncbi.nlm.nih.gov/pubmed/36347457
http://dx.doi.org/10.1016/j.ijid.2022.11.001
work_keys_str_mv AT oronskybryan couldnucleocapsidbeanextgenerationcovid19vaccinecandidateauthorsreply
AT larsonchristopher couldnucleocapsidbeanextgenerationcovid19vaccinecandidateauthorsreply
AT caroenscott couldnucleocapsidbeanextgenerationcovid19vaccinecandidateauthorsreply
AT reidtonyr couldnucleocapsidbeanextgenerationcovid19vaccinecandidateauthorsreply

Ejemplares similares